Bisect Therapeutics

bisect is a new antiviral company developing multiple, first-in-class, small molecule medicines against challenging drug targets across a wide range of disease areas that include viral and immune diseases. our efforts have given rise to a constellation of exciting discoveries, spanning from early drug hits to preclinical candidates. our success is based on the rapid translation of clinical and disease insights into target identification and development of novel drug molecules. at the core of our effort is the integration of structural and biophysical knowledge of disease targets to accelerate the pace and success of drug development.